Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05210036

HILT and US Therapies in Adhesive Capsulitis

Conditions: Adhesive Capsulitis of Shoulder, Pain, Disability Physical

Sex: All
Ages: 18 Years – 70 Years
Healthy volunteers: No
Phase: NA
Enrollment: 60
Sponsor: Balikesir University

Summary

Background: Adhesive capsulitis (AC) is a common musculoskeletal disease characterized by pain and limitation of movement in the shoulders of patients. Purpose: This study aimed to assess the effectiveness of short- and long-term therapeutic ultrasound (US) and high-intensity laser therapy (HILT) in the treatment of AC. Methods: A total of 60 patients with AC were randomized into two groups. Group I received US (15 sessions in total) and Group II received HILT (9 sessions in total) for 3 weeks. In addition, all the patients received 15 sessions of physical therapy programs (hot pack, TENS and therapeutic exercises). Assessments were made using VAS-Pain, Shoulder Pain and Disability Index (SPADI) and range of motion (ROM) with goniometer before and at the end of the treatment and in the posttreatment 1st and 6th months.

Eligibility Criteria

Inclusion Criteria: * Clinically diagnosed with primary (idiopathic) AC, * Pain and movement restriction in his or her shoulder for at least 3 months, * Restriction of passive external rotation in the involved shoulder restricted with less than 50% of the contralateral shoulder, * Normal radiography findings Exclusion Criteria: * Both shoulders were involved, * Other shoulder pathologies (glenohumeral osteoarthritis, calcific tendinitis, rotator cuff tear, etc.), * Cervical radiculopathy, * Brachial plexus lesion, * Neuromuscular disorders, * Inflammatory rheumatic disorders, * Malignancy, * Acute trauma, * Patients who had fracture affecting the involved shoulder joint, patients who underwent a surgical intervention, patients who underwent intraarticular injection for the involved shoulder within the last 6 months, * Patients who received physical therapy for the glenohumeral joint within the last 1 year, and * Photoallergy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05210036). StuddyBuddy aggregates publicly available trial information.